Breaking News
eThalED Webinar Series: Current Standard Care & New Advances in Iron Chelation
TIF Webinar Fridays Are Back With A New Session on “Heart Disease In Thalassaemia”
Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia
Thal e-Course Webinar Series: Iron Monitoring in Thalassaemia
Johnson & Johnson Pauses Clinical Trials For Its Covid-19 Vaccine Over Participant’s Illness
Hidden Victims Of The Pandemic: Blood Bank Stocks Run Low As India’s Healthcare System Buckles
New Video Series on Living With Thalassaemia by CDC & CAF
Fulcrum Therapeutics to Initiate Phase 1 Trial with FTX-6058 for Sickle Cell Disease
TIF Develops Mobile Application To Support Patients With Thalassaemia
Coming Up This Week: ”Iron Monitoring in Thalassaemia” Webinar for Patients
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
TIF
Αρχική
Ποιοί είμαστε
Εκπαίδευση
Διεθνείς Δραστηριότητες
Θέσεις & Πολιτικές
Έργα
Δημοσιεύσεις
Ειδήσεις & Εκδηλώσεις
Επικοινωνία
Search for
RSS
Instagram
YouTube
Twitter
Facebook
eThalED Webinar Series: Current Standard Care & New Advances in Iron Chelation
TIF Webinar Fridays Are Back With A New Session on “Heart Disease In Thalassaemia”
Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in β-Thalassaemia
Thal e-Course Webinar Series: Iron Monitoring in Thalassaemia
Johnson & Johnson Pauses Clinical Trials For Its Covid-19 Vaccine Over Participant’s Illness
Hidden Victims Of The Pandemic: Blood Bank Stocks Run Low As India’s Healthcare System Buckles
Highlights
TIF e-Academy
COVID-19 Pandemic
Clinical Trial Updates
Renzo Galanello Fellowships
International Thalassaemia Day
The Thalia Project
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Περισσότερα
Έγινε, ευχαριστώ
